Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
Cormorant Asset Management LP | 3,025,000 6.110% |
632,703 (+26.45%) |
Filing History |
| 2022-02-14 2:35 pm Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
PRICE T ROWE ASSOCIATES INC | 3,811,568 7.700% |
1,265,783 (+49.72%) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
The Vanguard Group | 3,877,339 7.840% |
436,879 (+12.70%) |
Filing History |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Turning Point Therapeutics, Inc. TPTX |
FMR CORP | 1,398,602 2.826% |
-1,775,067 (-55.93%) |
Filing History |
| 2022-02-04 09:24 am Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
WELLINGTON MANAGEMENT CO LLP | 4,009,654 8.100% |
4,009,654 (New Position) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
BLACKROCK INC BLK |
3,783,325 7.600% |
625,938 (+19.82%) |
Filing History |
| 2021-06-10 11:37 am Sale |
2021-06-09 | 13G | Turning Point Therapeutics, Inc. TPTX |
FMR CORP | 3,173,669 6.456% |
-3,041,693 (-48.94%) |
Filing History |
| 2021-04-07 4:39 pm Sale |
2021-03-01 | 13D | Turning Point Therapeutics, Inc. TPTX |
ORBIMED ADVISORS LLC | 1,743,950 3.600% |
-283,600 (-13.99%) |
Filing History |
| 2021-02-16 3:12 pm Sale |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
Cormorant Asset Management LP | 2,392,297 4.960% |
-1,004,353 (-29.57%) |
Filing History |
| 2021-02-16 12:24 pm Purchase |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
PRICE T ROWE ASSOCIATES INC | 2,545,785 5.200% |
2,545,785 (New Position) |
Filing History |
| 2021-02-10 11:57 am Purchase |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
The Vanguard Group | 3,440,460 7.140% |
1,475,226 (+75.07%) |
Filing History |
| 2021-02-08 10:35 am Purchase |
2021-02-05 | 13G | Turning Point Therapeutics, Inc. TPTX |
FMR CORP | 6,215,362 12.902% |
1,374,716 (+28.40%) |
Filing History |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
BLACKROCK INC BLK |
3,157,387 6.600% |
1,026,556 (+48.18%) |
Filing History |
| 2020-11-06 5:26 pm Purchase |
2020-10-29 | 13D | Turning Point Therapeutics, Inc. TPTX |
GLAXOSMITHKLINE PLC | 2,273,618 4.900% |
4,958 (+0.22%) |
Filing History |
| 2020-05-26 5:06 pm Purchase |
2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX |
GLAXOSMITHKLINE PLC | 2,268,660 5.500% |
276,110 (+13.86%) |
Filing History |
| 2020-05-22 4:54 pm Unchanged |
2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX |
ORBIMED ADVISORS LLC | 2,027,550 4.900% |
0 (Unchanged) |
Filing History |